Prothegen Inc.

Prothegen Inc.

Biotechnology Research

Palo Alto, California 72 followers

Next generation medicines targeting ferroptosis

About us

One million cells die every second in your body. In diseases such as Parkinson's, brain cells die when we would like them to live. In cancer, cells refuse to die, and instead grow into a tumor. What if we could switch cell death on and off? Founded by world leaders in ferroptosis, Prothegen is an early-stage biotech company delivering revolutionary therapies to regulate cell death with exquisite precision. Targeting new cell death programs opens a new way to treat diseases previously considered untreatable such as stroke, neurodegeneration and cancer.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Palo Alto, California
Type
Privately Held

Locations

Employees at Prothegen Inc.

Similar pages

Browse jobs

Funding

Prothegen Inc. 2 total rounds

Last Round

Pre seed
See more info on crunchbase